Myosin XVA

Alternative Names

  • MYO15A
  • Myosin XV
  • MYO15
Back to search Result
OMIM Number

602666

NCBI Gene ID

51168

Uniprot ID

Q9UKN7

Length

71,539 bases

No. of Exons

67

No. of isoforms

2

Protein Name

Unconventional myosin-XV

Molecular Mass

395293Da

Amino Acid Count

3530

Genomic Location

chr17:18,108,706-18,180,244

Gene Map Locus
17p11.2

Description

Myosins are molecular motor proteins that drive the movement of actin filaments via ATP hydrolysis to facilitate muscle contraction, organelle trafficking, cell movement, cytokinesis, and signal transduction. Myosin XVa is unique unconventional myosin protein that is characterized by the presence of a long 1,200-residue N-terminal domain extension (coded by exon 2) that is alternatively spliced to generate distinct class 1 and class 2 protein isoforms. Myosin XVa also contains domains that are conserved within the myosin protein family, including the motor domain, IQ motifs (calmodulin/myosin light chain binding), MyTh4 domains (Myosin-Tail like Homology region 4), FERM motifs (4.1 protein, Ezrin, Radixin, and Moesin), SH3 domain (Src Homology 3), and the PDZ ligand domain.

MYO15A gene mutations in all domains, with the exception of the IQ domains in the neck region, are responsible for DFNB3 hearing loss. A larger number of DFNB3-causing mutations have been identified in families from Brazil, India, Indonesia, Iran, North America, Pakistan, and Turkey.

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_016239.3:c.3791C>AUnited Arab EmiratesNC_000017.11:g.18126381C>ALikely Pathogenic, Uncertain SignificanceDeafness, Autosomal Recessive 3NG_011634.1:g.22676C>A; NM_016239.3:c.3791C>A; NP_057323.3:p.Pro1264Gln
NM_016239.4:c.1454T>CLebanon; Saudi Arabiachr17:18120254Likely Benign, Uncertain SignificanceLikely PathogenicDeafness, Autosomal Recessive 3NG_011634.2:g.16549T>C; NM_016239.4:c.1454T>C; NP_057323.3:p.Val485Ala200532919195313
NM_016239.4:c.1634C>TLebanonchr17:18120434Benign, Likely Benign, Uncertain SignificanceLikely PathogenicDeafness, Autosomal Recessive 3NG_011634.1:g.16729C>T; NM_016239.4:c.1634C>T; NP_057323.3:p.Ala545Val199740747322120
NM_016239.4:c.3988C>TLebanonchr17:18127121Uncertain SignificanceLikely PathogenicDeafness, Autosomal Recessive 3NG_011634.1:g.23416C>T; NM_016239.4:c.3988C>T; NP_057323.3:p.Arg1330Cys374131038889066
NM_016239.4:c.5886C>AEgyptNC_000017.11:g.18142816C>ALikely PathogenicLikely PathogenicDeafness, Autosomal Recessive 3NG_011634.2:g.39111C>A; NM_016239.4:c.5886C>A; NP_057323.3:p.Tyr1962Ter2502899
NM_016239.4:c.5925G>AUnited Arab EmiratesNC_000017.11:g.18143580G>ABenign, Likely Benign, Pathogenic, Uncertain SignificanceUncertain SignificanceDeafness, Autosomal Recessive 3NG_011634.2:g.39875G>A; NM_016239.4:c.5925G>A; NP_057323.3:p.Trp1975Ter375290498203364
NM_016239.4:c.6347delYemenNC_000017.11:g.18145945delLikely PathogenicDeafness, Autosomal Recessive 3NG_011634.2:g.42240del; NM_016239.4:c.6347del; NP_057323.3:p.Lys2116ArgfsTer137
NM_016239.4:c.6503T>GUnited Arab EmiratesNC_000017.11:g.18146101T>GPathogenic, Uncertain SignificanceLikely PathogenicDeafness, Autosomal Recessive 3NG_011634.2:g.42396T>G; NM_016239.4:c.6503T>G; NP_057323.3:p.Leu2168Arg1567648703623382

Other Reports

Palestine

Shahin et al. (2010) carried out a molecular study to identify the genes responsible for inherited hearing loss, by using high-density SNP arrays to genotype the DNA of 155 relatives (including: 78 patients, 28 of their hearing siblings, and 49 parents) from 20 Palestinian consanguineous families with prelingual bilateral autosomal recessive non-syndromic hearing loss (NSHL). In 14 families, Shahin et al. (2010) identified the allele responsible for hearing loss by screening a single candidate gene, known to be associated with hearing loss, in the longest homozygous region. Among these 14 families, Shahin et al. (2010) identified a novel variant (c.7545G>T) in exon 35 of the MYO15A gene in two families with five affected sibs (two males and three females), and three female affected members, respectively. Splicing analysis revealed that the c.7545G>T mutation led to the creation of an alternate GT donor splice site and deletion of 7 nucleotides (c.7544-c.7550) from the message. The mis-spliced message alters the reading frame and is predicted to produce 11 novel amino acids prior to the introduction of a nonsense codon (Asp2403fsX2414). Sequence analysis of the cDNA demonstrated that the nonsense codon is stable and evades nonsense-mediated decay. This allele was homozygous in five out of 218 (2.3%) unrelated deaf probands, making MYO15A the third most common cause of non-syndromic deafness in the West Bank after connexin 26 and TRIOBP.

Using targeted DNA capture and massively parallel sequencing (MPS), Brownstein et al. (2011) screened 246 genes known to be responsible for human or mouse deafness in 11 probands of Jewish and Palestinian Arab origin and identified mutations associated with hearing loss in a subset of these probands and their extended families. Among these 11 families, one consanguineous family of Palestinian Arab origin included three sibs affected with congenital, profound, and recessive hearing loss. The proband in this family was homozygous for the novel mutation c.4240G>A (p.E1414K) in the MYO15A gene.

Tunisia

Belguith et al. (2009) carried out a molecular study on 77 Tunisian consanguineous families segregating recessive deafness. Genetic analysis revealed evidence of linkage to microsatellite markers for DFNB3 in four families. In two of these families, sequencing of MYO15A led to the identification of two novel homozygous mutations: a nonsense (c.4998C>A; p.C1666X) mutation in exon 17 and a splice site mutation in intron 54 (c.9229+1G>A). A novel mutation of unknown significance, c.7395+3G>C, was identified in the third family, and no mutation was found in the fourth family. This finding suggested the possibility that there are two distinct genes at the DFNB3 locus.

© CAGS 2024. All rights reserved.